XENOPORT INC 4
4 · XENOPORT INC · Filed Jul 6, 2016
Insider Transaction Report
Form 4
XENOPORT INCXNPT
HILLEMAN JERYL L
Director
Transactions
- Disposition to Issuer
Stock Options
2016-07-05$7.03/sh−15,000$105,450→ 0 totalExercise: $4.57Exp: 2024-06-11→ Common Stock (15,000 underlying) - Disposition to Issuer
Stock Options
2016-07-05$7.03/sh−15,000$105,450→ 0 totalExercise: $4.35Exp: 2026-05-17→ Common Stock (15,000 underlying) - Disposition to Issuer
Stock Options
2016-07-05$7.03/sh−15,000$105,450→ 0 totalExercise: $6.17Exp: 2023-05-14→ Common Stock (15,000 underlying) - Disposition to Issuer
Stock Options
2016-07-05$7.03/sh−15,000$105,450→ 0 totalExercise: $6.04Exp: 2025-05-19→ Common Stock (15,000 underlying) - Disposition to Issuer
Restricted Stock Units
2016-07-05$7.03/sh−5,000$35,150→ 0 total→ Common Stock (5,000 underlying) - Disposition to Issuer
Stock Options
2016-07-05$7.03/sh−15,000$105,450→ 0 totalExercise: $6.18Exp: 2022-05-16→ Common Stock (15,000 underlying) - Disposition from Tender
Common Stock
2016-07-05$7.03/sh−25,342$178,154→ 0 total
Footnotes (3)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated May 21, 2016, by and among XenoPort, Inc. ("XenoPort"), Arbor Pharmaceuticals, LLC ("Arbor") and AP Acquisition Sub, Inc. ("AP Acquisition Sub"), a wholly owned subsidiary of Arbor, immediately prior to the Acceptance Time (as defined in the Merger Agreement), each outstanding and unexercised option to purchase shares of common stock of XenoPort was fully vested, cancelled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash equal to: (A) $7.03 per share minus (B) the exercise price per share of common stock of XenoPort.
- [F2]Each restricted stock unit ("RSU") represents the right to receive one share of common stock of XenoPort.
- [F3]Pursuant to the terms of the Merger Agreement, immediately prior to the Acceptance Time (as defined in the Merger Agreement), each outstanding RSU was fully vested, cancelled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash equal to $7.03 per share.